Citation

Jay Lalezari, M.D., W. Keith Henry, M.D., Mary O'Hearn, M.D., Julio S.G. Montaner, M.D., Peter J. Piliero, M.D., Benoit Trottier, M.D., Sharon Lynn Walmsley, M.D., Calvin J. Cohen, M.D., M.Sc., Daniel R. Kuritzkes, M.D., Joseph J. Eron, Jr., M.D., Jain Chung, Ph.D., Ralph A. DeMasi, Ph.D., Lucille Donatacci, M.S., Claude Drobnes, M.D., John Delehanty, Ph.D., Miklos P. Salgo, M.D., Ph.D. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. New England Journal of Medicine. 2003 May 29; 384(22):2175-85.

Citation

Richard A. Zuckerman, William L.H. Whittington, Connie Celum, M.D., Tarquin Collis, Aldo J. Lucchetti, M.D., Jorge L. Sanchez, M.D., M.P.H., James P. Hughes, Robert W. Coombs, M.D., Ph.D. Factors associated with oropharyngeal human immunodeficiency virus shedding. Journal of Infectious Diseases. 2003 Jul 01; 188(1):142-5.

Citation

Philip M. Polgreen, Jinhua Xiang, Qing Chang, Jack T. Stapleton, M.D. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes and Infection. 2003 Nov 01; 5(13):1255-61.

Citation

Sharon Lynn Walmsley, M.D., W. Keith Henry, M.D., Christine Katlama, Mark Nelson, M.D., Antonella Castagna, Jacques Reynes, Ph.D., Bonaventura Clotet, M.D., Ph.D., James Hui, Miklos P. Salgo, M.D., Ph.D., Ralph A. DeMasi, Ph.D., John Delehanty, Ph.D. Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide. Journal of Infectious Diseases. 2003 Dec 15; 188(12):1827-33.

Citation

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Suzette Blanchard, M.S., Ph.D., Coleen Cunningham, M.D., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Mary Culnane, C.R.N.P., M.S., John L. Sullivan, M.D. Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose. Journal of Acquired Immune Deficiency Syndromes. 2003 Jun 01; 33(2):153-6.

Citation

Stuart E. Starr, M.D., Elizabeth J. McFarland, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Jane Pitt, M.D., Steven Douglas, M.D., Audra Deveikis, M.D., Myron Levin, M.D., Mobeen H. Rathore, M.D. Phase I/II Trial of Intravenous Recombinant Interleukin-2 in Human Immunodeficiency Virus-infected Children. AIDS. 2003 Oct 17; 17:2181-2189.

Citation

Patricia Lani Lee, Ph.D., Constantin Yiannoutsos, Ph.D., Thomas Ernst, Ph.D., Linda Chang, M.D., Christina M. Marra, M.D., Jeffrey G. Jarvik, M.D., M.P.H., Todd Richards, Edmund Kwok, Dennis Kolson, M.D., Ph.D., David M. Simpson, M.D., Cheuk Tang, Giovanni Schifitto, M.D., Leena Ketonen, Dieter J. Meyerhoff, Robert Lenkinski, Ph.D., Bradford A. Navia, M.D., R.Gilberto Gonzalez, M.D., Ph.D. A multi-center H MRS study of the AIDS dementia complex: validation and preliminary analysis. Journal of Magnetic Resonance Imaging. 2003 Jun 01; 17(6):625-33.

Citation

M. Ancukiewicz, Dianne M. Finkelstein, Ph.D., David A. Schoenfeld, Ph.D. Modelling the relationship between continuous covariates and clinical events using isotonic regression. Statistics In Medicine. 2003 Oct 30; 22(20):3151-9.

Citation

Nancy Radcliffe Reynolds, Ph.D. The problem of antiretroviral adherence: a self-regulatory model for intervention. AIDS Care. 2003 Feb 01; 15(1):117-124.